TFI International Announces 2020 Second Quarter Results
Second quarter operating income from continuing operations of $131.5 million compared to $149.0 million the same quarter last yearNet cash […]
Bullfrog Gold Summarizes Exploration/Development Progress and Plans at its Project in the Bullfrog Mining District of Nevada
GRAND JUNCTION, Colo., July 27, 2020 (GLOBE NEWSWIRE) — via NetworkWire – Bullfrog Gold Corp (BFGC:OTCQB; BFG:CSE; 11B:FSE) (“Bullfrog”, “BFGC” […]
Hooker Furniture Finalizes Q1 Financial Results
MARTINSVILLE, Va., July 27, 2020 (GLOBE NEWSWIRE) — Hooker Furniture Corporation (NASDAQ-GS: HOFT) today reported finalized financial results for its […]
Y-mAbs Announces Data to be Presented at 2020 SIOP
NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical […]
BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020
RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company […]
Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020
NEWPORT BEACH, Calif., July 27, 2020 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric […]
Sientra to Report Second Quarter 2020 Financial Results on August 10, 2020
SANTA BARBARA, Calif., July 27, 2020 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical […]
Editas Medicine Appoints Gad Berdugo as Chief Business Officer
CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced […]
Waterstone Financial, Inc. Announces Results of Operations for the Quarter and Six Months Ended June 30, 2020
WAUWATOSA, Wis., July 27, 2020 (GLOBE NEWSWIRE) — Waterstone Financial, Inc. (NASDAQ: WSBF), holding company for WaterStone Bank, reported net […]
TCR² Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy […]
